During July/August 2021, we have published three new Cochrane reviews in Issues 7 and 8, 2021 of the Cochrane Database of Systematic Reviews.
New reviews – July
- Popp M, Stegemann M, Metzendorf M-I, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD015017. DOI: 10.1002/14651858.CD015017.pub2.
Read the LSTM news story here: https://www.lstmed.ac.uk/news-events/news/ivermectin-treatment-in-humans-for-covid-19
Read the Cochrane.org article here: https://www.cochrane.org/news/ivermectin-preventing-and-treating-covid-19
Listen to the Podcast here: https://www.cochrane.org/podcasts/10.1002/14651858.CD015017.pub2
New reviews – August
- Ochodo EA, Guleid F, Deeks JJ, Mallett S. Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD013207. DOI: 10.1002/14651858.CD013207.pub2.
- Nathavitharana RR, Lederer P, Chaplin M, Bjerrum S, Steingart KR, Shah M. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD014641. DOI: 10.1002/14651858.CD014641.
Throughout 2021, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter:
https://twitter.com/Cochrane_IDG
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.